Genome scan in Chinese revealed an association of blood pressure with the microsatellite marker D17S1303, which lies in a quantitative trait locus for the abdominal obesity-metabolic syndrome (AOMS2) at 17p12 on chromosome 17. We previously reported that D17S1303 was associated with hypertension and obesity. Therefore, we studied 10 single nucleotide polymorphisms (SNP) within 3 kb of D17S1303. One hundred and eighty hypertensive subjects (91 men, 89 women, age 53712 years) and 180 normotensive matched controls (91 men, 89 women, age 52711) were genotyped using the Sequenom genotyping platform. Allelic frequencies in these Chinese subjects differed from those reported for Caucasians. Three SNPs (rs11656507, rs1357926, rs852319) were homozygous in our subjects. The genotype frequencies of rs852320, rs852321 and rs852322 did not differ between hypertensive and normotensive subjects. However, there were significant differences for rs1525402 (P ¼ 0.048), rs2692343 (P ¼ 0.022), rs2692344 (P ¼ 0.017) and rs2321313 (P ¼ 0.028). A four-locus haplotype comprising G at rs1525402, C at rs2692343, C at rs2692344 and G at rs2321313 was associated with lower systolic blood pressure (P ¼ 0.023) and normotension (P ¼ 0.048). Our results provide further evidence that there is a gene, as yet unidentified, influencing blood pressure in the vicinity of D17S1303 in a quantitative trait locus for abdominal obesity-metabolic syndrome at 17p12.
Introduction
Patients with hypertension usually do not have a secondary cause. Primary or essential hypertension is likely to result from the interaction between genetic predisposition and environmental factors. 1 The environmental factors that lead to hypertension are well worked out. Of these, overweight or obesity is undoubtedly one of the most important. 2 The search for causative genes for hypertension has been ongoing for at least a decade. Many promising candidate genes have been examined. Thus, a gene that causes hypertension may also be associated with obesity and other components of the metabolic syndrome.
A genome scan of blood pressure-regulating genes done in Chinese sib-pairs undertaken in Anhui in collaboration with Harvard University showed that the microsatellite marker D17S1303, which consists of GATA repeats, had a high LOD score. 3 This marker lies close to a quantitative trait locus for abdominal obesity-metabolic syndrome (AOMS2) at 17p12 on chromosome 17. 4 Recently, we have reported that D17S1303 was associated with hypertension. 5 The number of GATA repeats correlated inversely with diastolic blood pressure and BMI. Nine GATA repeats were associated with hypertension while 14 GATA repeats were associated with normotension.
Chromosome 17 has been studied in genome scans, 6, 7 but the region around D17S1303 has not been intensively studied and there is a lack of reports of single nucleotide polymorphisms or genes in its close proximity. In case-control studies, single nucleotide polymorphisms are preferable to microsatellite markers, which are highly polymorphic. Therefore, we set out to study SNPs around D17S1303 and investigate their association with hypertension.
Methods

Subjects
The study protocol was approved by the Faculty Ethics Committee. We studied 360 subjects, 180 hypertensive patients and 180 normotensive controls with their informed consent. Hypertensive subjects were recruited from the Hypertension Clinic of a teaching hospital. Hypertension was defined as systolic blood pressure X140 mm Hg, or a diastolic blood pressure X90 mm Hg on at least three separate occasions. Patients on antihypertensive treatment and those who had been diagnosed as hypertensive by the above criteria were also eligible. Patients with secondary hypertension (e.g. Cushing's syndrome, Conn's syndrome, phaeochromocytoma, acromegaly, renal artery stenosis, coarctation, glomerulonephritis and pyelonephritis) were excluded. Subjects who received drug treatment for diabetes mellitus were also excluded. Normotensive controls, matched for age and sex, were recruited from the Hong Kong Cardiovascular Risk Factor Prevalence Survey-2 (CRISPS2) cohort. These subjects had been randomly chosen from the general population. 8, 9 Physical examination (including measurement of height, weight, body fat, waist and hip circumference), urinalysis and electrocardiography were performed and a full medical history (including past medical history, drug history, family history, smoking status, alcohol intake and exercise habit) was obtained. Waist circumference was measured half way between the xiphisternum and the umbilicus while hip circumference was measured at the level of the greater trochanters. 10 Percentage body fat was estimated by measuring the bioelectrical impedance (Tanita TBF300, Tanita Corporation, Tokyo, Japan).
11
Subjects were studied in the morning after fasting overnight. The blood pressure of each patient was measured by a trained nurse manually after at least 5 min of rest. Blood pressure was measured thrice at 5 min intervals. The first measurement was to familiarize the patient with the procedure. The two subsequent systolic and phase V diastolic blood pressure readings were recorded to the nearest 2 mm Hg, the mean of which was used for data analysis.
After resting for at least 5 min, 20 ml venous blood was taken from a forearm vein for a full blood count (haemoglobin, haematocrit, differential white count and platelet count), renal and liver function tests (sodium, potassium, urea, creatinine, glucose, bilirubin, albumin, ALT and alkaline phosphatase), plasma insulin and lipid profile. Insulin resistance was measured using the homeostasis model assessment of insulin resistance index (HOMA-IR), which is the product of the fasting plasma insulin (FPI) concentration in mU/l and fasting plasma glucose (FPG) in mmol/l divided by 22.5.
12 Pancreatic b-cell function was estimated using HOMA-b%, which equals (20 Â FPI)/(FPG -3.5).
Genetic analysis
Genomic DNA was extracted from the buffy coat using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Candidate SNPs within 3 kb of D17S1303 were selected from an SNP database ( Figure 1) . 13 Highthroughput genotyping of the SNPs was performed using the Sequenom MassARRAY system (Sequenom, San Diego CA, USA) which utilizes Matrix Assisted Laser Desorption Ionization-Time Of Flight Figure 1 The locations of the single nucleotide polymorphisms investigated and the microsatellite marker D17S1303 on chromosome 17.
(MALDI-TOF) technology. Primers for SNP detection were designed using MassARRAY AssayDesign software (Sequenom).
Statistical analysis
Data were analysed using a statistical software programme (SPSS for Windows, ver. 11.0, SPSS Inc., Chicago, USA). Comparison of clinical characteristics in the hypertensive and normotensive groups or in groups with different genotypes were performed using unpaired t-test or Mann-Whitney U-test and w 2 -test for continuous and categorical variables respectively. Genotype frequencies for each SNP were tested for Hardy-Weinberg equilibrium. We used the programme Haploview (ver. 3.2) to calculate the r 2 among all possible SNP pairs in order to assess the degree of linkage disequilibrium.
14 The parameter r 2 is independent of allele frequency and is appropriate for modest sample sizes. 15, 16 Haplotypes were predicted using the programme PHASE (version 2.1), which implements a Bayesian method for estimating haplotypes from population genotype data. [17] [18] [19] A two-tailed P-value less than 0.05 was considered statistically significant. With the study sample size, there was 95% power to detect an odds ratio of 2.5 for a minor allele with a frequency greater than 0.1. Table 1 shows the characteristics of the 180 hypertensive subjects and 180 normotensive controls studied. There were no significant differences in the male:female ratio, age and alcohol consumption between the normotensive and hypertensive groups, but there were as expected, significant differences in blood pressure, weight, BMI, percentage body fat, HDL-cholesterol, plasma insulin and HOMA-IR. In the hypertensive group, 45 subjects (25%) were on antihypertensive drug treatment. Table 2 shows the pairwise r 2 among genotyped SNPs. Three SNPs (rs11656507, rs1357926, rs852319) were homozygous in our subjects and therefore not shown. The average r 2 value across all SNP pairs was 0.46. The SNP pairs, rs852321 and rs852322, and the three SNPS, rs2692343, rs2692344 and rs2321313, exhibit a high degree of linkage Table 3 . Genotype frequencies in these Chinese subjects differed from those reported for Caucasians. 13 There were no significant deviations of the observed genotype frequencies from Hardy-Weinberg equilibrium. The genotype frequencies of rs852320, rs852321 and rs852322 did not differ significantly between hypertensive and normotensive subjects (P ¼ 0.171, P ¼ 0.464 and P ¼ 0.196, respectively). However, the genotype frequencies of rs1525402, rs2692343, rs2692344 and rs2321313 differed between hypertensive and normotensive subjects (P ¼ 0.048, P ¼ 0.022, P ¼ 0.017 and P ¼ 0.028, respectively) ( Table 3) . Table 4 shows the systolic and diastolic blood pressure in subjects with different genotypes. The AA genotype at rs1525402 was associated with higher systolic blood pressure (P ¼ 0.02). There was a small difference in systolic blood pressure between subjects with or without the CC genotype at rs2692344 (P ¼ 0.049).
Results
Baseline characteristics
SNP genotyping
Haplotypes Four-locus haplotypes made up of rs1525402, rs2692343, rs2692344 and rs2321313 were analysed. Table 5 shows the frequencies of ACCG, AAGA and GCCG haplotypes. ACCG and AAGA were common and had a frequency of 0.445 and 0.443, respectively. ACCG was not associated with hypertension (P ¼ 0.908) but AAGA was more common among hypertensive subjects (P ¼ 0.022). GCCG had a frequency of 0.109 and was less common among hypertensive patients (P ¼ 0.048). The GCCG haplotype was associated with lower systolic blood pressure (P ¼ 0.023) ( Table 6) .
Stepwise regression with hypertension as the dependent variable and the various SNPs and haplotypes as independent variables showed that rs2692343 was the best predictor of hypertension (b ¼ 0.058, P ¼ 0.021). Neither rs2692343, other SNPs or any of the haplotypes are related signifi- 
Discussion
The most important finding of this study was the association of several SNPs at 17p12 with hypertension. The haplotype comprising G at rs1525402, C at rs2692343 and rs2692344, and G at rs2321313 was associated with lower systolic blood pressure and was less frequent among hypertensive patients. These new findings confirm and extend previous reports of the association of 17p12 with hypertension. [3] [4] [5] Our findings should be interpreted with a degree of caution. Single nucleotide polymorphisms that are close to each other would be expected to show linkage disequilibrium and similar associations with a particular trait. Therefore, the association of several SNPs or a haplotype with hypertension may be more a single SNP effect. Moreover, there might be other as yet unidentified SNPs in the region that are more strongly associated with hypertension. Conversely, our study did not have the power to detect weak associations between SNPs and hypertension. Thus, there is a need for replication of our study in an independent and larger data set.
In our population, blood pressure is related to indices of obesity and sodium intake. 2, [20] [21] [22] The relationship between obesity and raised blood pressure is expected because both are components of the metabolic syndrome, which is a clustering of abdominal obesity, elevated blood pressure, blood glucose and triglycerides, and low levels of highdensity lipoprotein cholesterol (HDLC). 23 Insulin resistance is believed to be a key underlying metabolic abnormality in the syndrome. 24, 25 Our hypertensive and age-and sex-matched normotensive subjects differed not just in blood pressure, but also in the other aspects of the metabolic syndrome. We believe that obesity, particularly central obesity, is an early abnormality in the cardiovascular continuum. 10, 26 Increased abdominal adiposity leads to a state of chronic low-grade inflammation, insulin resistance and endothelial dysfunction. [27] [28] [29] Adipocytes in adipose tissues secrete adipokines such as leptin, adiponectin and acylation-stimulating protein (ASP) that regulate obesity. 30 Leptin suppresses appetite, while adiponectin increases insulin sensitivity. Acylation-stimulating protein, a cleavage product of complement C3, stimulates triacylglycer- The four-locus haplotypes consist of rs1525402, rs2692343, rs2692344 and rs2321313. ol synthesis and its storage in adipocytes. Genome scan revealed two loci, 3q27 and 17p12, associated with the metabolic syndrome. 4 The former is near the adiponectin gene. The latter, AOMS2, is related to plasma levels of leptin 4 and ASP. 31 Neither the gene coding for leptin nor ASP (C3) is on chromosome 17, so there is an unidentified gene in this locus that determines abdominal obesity. The polymorphisms we investigated all lie within this quantitative trait locus. This locus is associated with hypertension, as shown in the genome scan in Chinese sib-pairs in Anhui. 3 We previously reported that D17S1303 was associated with hypertension and obesity. 5 We now found four SNPs that are a few kilobases from D17S1303 and within the AOMS2 quantitative trait locus are associated with hypertension. These consistent findings in different populations using diverse genetic approaches collectively suggest a high probability of a disease susceptibility gene in the locus.
In conclusion, our study showed that SNPs at 17p12 in Hong Kong Chinese are associated with hypertension. This is further evidence that a gene influencing blood pressure is in the vicinity of D17S1303, in a quantitative trait locus for abdominal obesity-metabolic syndrome. Our results should prompt the fine mapping of this part of chromosome 17, so as to identify the gene linked to hypertension and the metabolic syndrome, although final proof would require study of the function and dysfunction of the gene. 32 
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